Cite

HARVARD Citation

    Sasaki, R. et al. (2022). Impact of lenvatinib on renal function compared to sorafenib for unresectable hepatocellular carcinoma. Medicine. 101 (19), pp. e29289-. [Online]. 
  
Back to record